Praxis Precision Medicines Files 8-K on Shareholder Vote Matters
Ticker: PRAX · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1689548
| Field | Detail |
|---|---|
| Company | Praxis Precision Medicines, Inc. (PRAX) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Praxis Precision Medicines filed an 8-K on shareholder vote matters. Expect updates on corporate actions.
AI Summary
Praxis Precision Medicines, Inc. filed an 8-K on June 27, 2025, reporting on matters submitted to a vote of security holders as of June 26, 2025. The filing details the company's corporate information, including its incorporation in Delaware and principal executive offices in Boston, Massachusetts.
Why It Matters
This filing indicates that important decisions requiring shareholder approval were made or are being reported, which could impact the company's strategic direction and governance.
Risk Assessment
Risk Level: low — This is a routine corporate filing reporting on matters submitted to a vote, not a significant event like a merger or financial distress.
Key Players & Entities
- Praxis Precision Medicines, Inc. (company) — Registrant
- June 26, 2025 (date) — Date of earliest event reported
- June 27, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Boston, Massachusetts (location) — Address of principal executive offices
FAQ
What specific matters were submitted to a vote of security holders?
The filing does not specify the exact matters submitted to a vote, only that it is reporting on 'Submission of Matters to a Vote of Security Holders'.
When was the earliest event reported in this 8-K?
The earliest event reported was on June 26, 2025.
What is the company's principal executive office address?
The principal executive offices are located at 99 High Street, 30th Floor, Boston, Massachusetts 02110.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the company's state of incorporation?
The company is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding Praxis Precision Medicines, Inc. (PRAX).